BL
Insider
Baker Bros. Advisors (GP) LLC
DirectorBaker Bros. Advisors (GP) LLC (Director) filed 3 Form 4 reports as a reporting entity in the past 24 months (2 purchases, 1 sale), most often in BCYC. Across 2 priced purchase filings, the average 21-session return was -9.0% from execution and -6.6% from disclosure (delay-adjusted; derived). The largest single filing was $190.5M of ONC (732,827 sh across 2 lots, as filed), executed Feb 28 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-9.0%
avg across 2 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-6.6%
same 2 filings, from disclosure
Filings, ttm
3
2 buys · 1 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$240.5M
shares × price, as filed
Last traded
Jun 30 2025
Filed Jun 30 2025
Median ADV $116.4M across their filed names
Open performance→Volume by month
Buys $50.0M
Sells $190.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Not on file
1 filing
Sector per market data · by filing · past 24 months
Most traded names
BCYC
BCYC
BCYC · 1 buy · 0 sells
1 filing
KYMRRecent filings
KYMRPURCHASE
Kymera Therapeutics, Inc.
View filing →
$28.8M655,500 sh across 2 lots
Exec Jun 30 2025
Filed Jun 30 2025 · 5:30 PM ET ONCSALE BeOne Medicines AG View filing → $190.5M
732,827 sh across 2 lots
Exec Feb 28 2025
Filed Feb 28 2025 · 5:30 PM ET BCYCPURCHASE BICYCLE THERAPEUTICS PLC View filing → $21.1M
1,477,015 sh across 8 lots
Exec Dec 13 2024
Filed Dec 17 2024 · 5:30 PM ET